搜索结果：Antibiotics

Ribosome-targeting antibiotics, such as chloramphenicol, stall elongating ribosomes during protein synthesis, disrupting mRNA translation. These antibiotic-induced pauses occur stochastically, alter collective ribosome dynamics and transiently block protein production on the affected transcript. Existing models of ribosome traffic often rely on idealized assumptions, such as infinitely long mRNAs and simplified pausing dynamics, overlooking key biological constraints. Here, we develop a Totally Asymmetric Simple Exclusion Process (TASEP) that incorporates stochastic particle pausing, using experimentally determined pausing and unpausing rates to model the effects of ribosome-targeting antibiotics. We introduce a Single-Cluster approximation, which is analytically treatable, tailored to capture the biologically relevant regime of rare and long antibiotic-induced pauses. This biologically constrained model reveals three key insights: (i) the inhibition of antibiotic-induced translation strongly depends on transcript length, with longer transcripts being disproportionately affected; (ii) reducing ribosome initiation rates significantly mitigates antibiotic vulnerability; and (iii) inh

Antibiotic resistance, which is a serious healthcare issue, emerges due to uncontrolled and repeated antibiotic use that causes bacteria to mutate and develop resistance to antibiotics. The Antibiotics Time Machine Problem aims to come up with treatment plans that maximize the probability of reversing these mutations. Motivated by the severity of the problem, we develop a risk-averse approach and formulate a scenario-based mixed-integer linear program with a conditional value-at-risk objective function. We propose a risk-averse scenario batch decomposition algorithm that partitions the scenarios into manageable risk-averse subproblems, enabling the construction of lower and upper bounds. We develop several algorithmic enhancements in the form of stronger no-good cuts and symmetry breaking constraints in addition to scenario regrouping and warm starting. We conduct extensive computational experiments for static and dynamic versions of the problem on a real dataset and demonstrate the effectiveness of our approach. Our results suggest that risk-averse solutions can achieve significantly better worst-case performance compared to risk-neutral solutions with a slight decrease in terms o

Growth in bacterial populations generally depends on the environment (availability and quality of nutrients, presence of a toxic inhibitor, product inhibition..). Here, we build a model to describe the action of a bacteriostatic antibiotic, assuming that this drug inhibits an essential autocatalytic cycle involved in the cell metabolism. The model recovers known growth laws, can describe various types of antibiotics and confirms the existence of two distinct regimes of growth-dependent susceptibility, previously identified only for ribosome targeting antibiotics. Interestingly, below a certain threshold in terms of antibiotic concentration, a coexistence between two values of the growth rate is possible, which has also been observed experimentally. Interesting extensions of the model include the antagonistic effect of two drugs targeting different autocatalytic cycles or the production of an inhibiting waste.

Antibiotic resistance (AR) is one of the greatest public health challenges worldwide. Processes that allow the reduction of AR predictor of hospital wastewater has become crucial process that contributes to the protection of public health and the environment. The aim of this review article was to compare the effectiveness of various methods for treatment hospital wastewater in eliminating antibiotic-resistant bacteria (ARB) and degrading antibiotic resistance genes (ARGs) and antibiotics. A large number of studies dealing with wastewater treatment suggest that this topic is highly relevant and that new solutions are being developed to limit the spread of AR. Some wastewater treatment techniques have been in use for decades. Despite the negative effects of chlorine compounds, chlorination is still applied to eliminate ARB, ARGs, and drug metabolites. Ultraviolet (UV) radiation and ozonation have long been recognized for their treating properties. In the literature, advanced oxidation processes (AOPs) are increasingly often indicated as the most effective alternative to conventional treatment methods. Various methods for disinfecting hospital wastewater were reviewed and their enviro

In this study, we synthesized S functionalized graphene sponge electrode and applied it for electrochemical oxidation of five commonly used antibiotics, namely sulfamethoxazole, trimethoprim, ofloxacin, roxithromycin and erythromycin, and inactivation of a multidrug resistant Escherichia coli, E. coli. The experiments were performed using real drinking water in a flow through, one pass mode. Highly polar antibiotics such as sulfamethoxazole did not adsorb onto the graphene sponge but were completely removed, i.e., more than 95% removal, at low applied current densities, 14.5 A m2. Antibiotics with high affinity for pi pi interactions were completely removed already in the open circuit, and current application led to their further degradation. S doped graphene sponge anode resulted in 4.5 log removal of a multi-drug resistant E. coli at 29 A m2. There was no regrowth of bacteria observed during storage of the electrochemically treated samples, suggesting that the treatment severely impacted the cell viability. Further E. coli removal of 0.7 log was observed after the storage of electrochemically treated samples. The energy consumption of a continuously operated electrochemical syste

Antimicrobial resistance (AMR) is escalating and outpacing current antibiotic development. Thus, discovering antibiotics effective against emerging pathogens is becoming increasingly critical. However, existing approaches cannot rapidly identify effective molecules against novel pathogens or emerging drug-resistant strains. Here, we introduce ApexOracle, an artificial intelligence (AI) model that both predicts the antibacterial potency of existing compounds and designs de novo molecules active against strains it has never encountered. Departing from models that rely solely on molecular features, ApexOracle incorporates pathogen-specific context through the integration of molecular features captured via a foundational discrete diffusion language model and a dual-embedding framework that combines genomic- and literature-derived strain representations. Across diverse bacterial species and chemical modalities, ApexOracle consistently outperformed state-of-the-art approaches in activity prediction and demonstrated reliable transferability to novel pathogens with little or no antimicrobial data. Its unified representation-generation architecture further enables the in silico creation of

Antimicrobial resistance is a silent pandemic that is being exacerbated by the uncontrolled use of antibiotics. Since the discovery of penicillin, we have been largely dependent on microbe-derived small molecules to treat bacterial infections. However, the golden era of antibiotics is coming to an end as the emergence and spread of antimicrobial resistance against these antibacterial compounds is outpacing the discovery and development of new antibiotics. The current antibiotic market suffers from various shortcomings, including the absence of profitability and investment. However, the most important underlying issue of traditional antibiotics arises from the inherent properties of these small molecules being mostly broad-spectrum and non-programmable. As the scientific knowledge of microbes progresses, the scientific community is starting to explore entirely novel approaches to tackling antimicrobial resistance. One of the most prominent approaches is to develop next-generation antibiotics. In this review, we discuss three innovations of next-generation antibiotics compared to traditional antibiotics as specificity, evolvability, and non-immunogenicity. We present a number of pote

Due to the permanent harm to human health and ecosystem balance, antibiotic pollution in water has become an important direction of current environmental governance. Spherical metal oxides (SMOs) have been frequently utilized as effective heterogeneous photocatalysts for the efficient degradation of antibiotics due to the unique properties (e.g., strong light absorption ability, high separation efficiency of photo-generated electron hole pairs, and good catalytic activity). This review will firstly focus on summarizing the rational design and synthesis of SMOs with various tuned microstructures such as hollow, porous shell, yolk shell, core shell, and nanoflowers. These structures can expose more active sites, achieve a higher utilization rate of light, enhance the mass transfer efficiency and improve the effective diffusion of reactive oxygen species (ROS). Secondly, this review will mainly analyze the intrinsic relationship between the structure of SMOs and its photocatalytic property, the ability to generate ROS, and the degradation pathway for antibiotics. Moreover, the photocatalytic mechanisms and recent progress of different SMOs catalysts for degrading typical antibiotics a

Antibiotics resistance has caused much complication in the treatment of diseases, where the pathogen is no longer susceptible to specific antibiotics and the use of such antibiotics are no longer effective for treatment. A recent study that utilizes digital organisms suggests that complete elimination of specific antibiotic resistance is unlikely after the disuse of antibiotics, assuming that there are no fitness costs for maintaining resistance once resistance are established. Fitness cost are referred to as reaction to change in environment, where organism improves its' abilities in one area at the expense of the other. Our goal in this study is to use digital organisms to examine the rate of gain and loss of resistance where fitness costs have incurred in maintaining resistance. Our results showed that GC-content based fitness cost during de-selection by removal of antibiotic-induced selective pressure portrayed similar trends in resistance compared to that of no fitness cost, at all stages of initial selection, repeated de-selection and re-introduction of selective pressure. Paired t-test suggested that prolonged stabilization of resistance after initial loss is not statistical

The term bacteriophage means killer or eater of bacteria. They were initially discovered by F.W. Twort and later on, Felix d'Herelle unveiled them to the world in 1910. Phage therapy has arisen as a favorable option to conventional antibiotics by reducing the multinational problem of increasing antibacterial resistance. These virulent viruses particularly prey on and contaminate bacterial strains and aid in fighting bacterial diseases. Researchers are performing various clinical trials on the bacteriophage to tackle pathogenic bacterial infections, varying from typical illnesses to highly invulnerable biofilms that cannot be treated with antibiotics. The primary experiments demonstrated that phage therapy has fewer consequences than traditional antimicrobial drugs. It is safer to use and show results within a few days. Although phage therapy has a wide range of promising results, but it also encounters diverse obstacles. One is that they are host-specific and can merely be used for personalized therapy. As thousands of bacteria can cause disease, clinicians have to construct a library of phage viruses. For successful treatment, an analysis of versatility, stability, and immune inte

The widespread practice of delivering antibiotics through drinking water to livestock leads to considerable variability in exposure levels among animals, raising concerns regarding disease outbreaks and the emergence of antibiotic resistance. This variability is primarily driven by three pivotal factors: fluctuations in drug concentration within water pipes, variances in drinking behavior among animals, and differences in individual pharmacokinetic parameters. This article introduces an approach aimed at improving medication distribution by customizing it according to the drinking patterns of pigs, without escalating the medication dose. As examples, we demonstrate that incorporating the drinking behavior into the delivery of amoxicillin results in an increase in the percentage of piglets reaching an AUC/MIC ratio greater than 25h. Specifically, with Pasteurella multocida, the percentage rises from 30% to at least 60%, while with Actinobacillus pleuropneumoniae, it increases from 20% to more than 70%.

Present study is dedicated to the problem of electrochemical analysis of multicomponent mixtures such as milk. A combination of cyclic voltammetry facilities and machine learning technique made it possible to create a pattern recognition system for antibiotic residues in skimmed milk. A multielectrode sensor including copper, nickel and carbon fiber was fabricated for the collection of electrochemical data. Chemical aspects of processes occurring at the electrode surface were discussed and simulated with the help of molecular docking and density functional theory modelling. It was assumed that the antibiotic fingerprint reveals as potential drift of electrodes owing to redox degradation of antibiotic molecules followed by pH change or complexation with ions present in milk. Gradient boosting algorithm showed the best efficiency towards training the machine learning model. High accuracy was achieved for recognition of antibiotics in milk. The elaborated method may be incorporated into existing milking systems at dairy farms for monitoring the residue concentrations of antibiotics.

Understanding how antibiotics inhibit bacteria can help to reduce antibiotic use and hence avoid antimicrobial resistance - yet few theoretical models exist for bacterial growth inhibition by a clinically relevant antibiotic treatment regimen. In particular, in the clinic, antibiotic treatment is time dependent. Here, we use a recently-developed model to obtain predictions for the dynamical response of a bacterial cell to a time-dependent dose of ribosome-targeting antibiotic. Our results depend strongly on whether the antibiotic shows reversible transport and/or low-affinity ribosome binding ("low-affinity antibiotic") or, in contrast, irreversible transport and/or high affinity ribosome binding ("high-affinity antibiotic"). For low-affinity antibiotics, our model predicts that growth inhibition depends on the duration of the antibiotic pulse, with a transient period of very fast growth following removal of the antibiotic. For high-affinity antibiotics, growth inhibition depends on peak dosage rather than dose duration, and the model predicts a pronounced post-antibiotic effect, due to hysteresis, in which growth can be suppressed for long times after the antibiotic dose has ended